Showing all 5 results
Nonalcoholic Fatty Liver Disease Leukopak
LeukoCore™ Nonalcoholic Fatty Liver Disease Leukopak products contain concentrated immune cells from donors with clinically confirmed nonalcoholic fatty liver disease (NAFLD), collected via apheresis. Ideal for high-yield studies on liver inflammation, metabolic-immune interactions, and biomarker discovery in fatty liver disorders.
Nonalcoholic Fatty Liver Disease PBMC
Nonalcoholic Fatty Liver Disease PBMC samples are isolated from donors with clinically confirmed Nonalcoholic Fatty Liver Disease (NAFLD). Ideal for investigating immune cell dysfunction, inflammation, and metabolic signaling involved in hepatic steatosis and disease progression.
Nonalcoholic Fatty Liver Disease Plasma
Nonalcoholic Fatty Liver Disease Plasma samples are collected from donors diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). Suitable for analyzing circulating biomarkers such as ALT, AST, adipokines, cytokines, and markers of insulin resistance and liver fibrosis.
Nonalcoholic Fatty Liver Disease Serum
Nonalcoholic Fatty Liver Disease Serum samples are derived from donors with confirmed Nonalcoholic Fatty Liver Disease (NAFLD). Useful for evaluating liver enzymes, lipid profiles, inflammatory markers, and fibrosis-related proteins to support biomarker discovery and clinical stratification.
Nonalcoholic Fatty Liver Disease Whole Blood
Nonalcoholic Fatty Liver Disease Whole Blood samples are obtained from donors with clinically diagnosed Nonalcoholic Fatty Liver Disease (NAFLD). Valuable for transcriptomic and genomic analysis, immune profiling, and identifying systemic contributors to metabolic liver disease.